NOS1 and schizophrenia: A previous review summarized the related mechanisms of sodium nitroprusside in the treatment of schizophrenia, such as the regulation of the NMDA-nNOS-cGMP signaling pathway, the relief of cerebral perfusion deficiency, the normalization of glutamate and dopaminergic neurotransmission function, and the strong antioxidant properties of the drug itself (19).